Mustang Bio, Inc.

Introduction

This page provides a comprehensive analysis of the known insider trading history of Brian Achenbach. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Brian Achenbach has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:MBIO / Mustang Bio, Inc. SVP, Fin. & Corp. Controller 144,729
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Brian Achenbach. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases MBIO / Mustang Bio, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in MBIO / Mustang Bio, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2018-11-20 MBIO Achenbach Brian 500 3.8742 15 125.9115 1,937 153 1413 19,258 994.22
2018-11-19 MBIO Achenbach Brian 1,000 4.2500 31 138.1250 4,250
2018-11-16 MBIO Achenbach Brian 1,000 4.3100 31 140.0750 4,310

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MBIO / Mustang Bio, Inc. Insider Trades
Insider Sales MBIO / Mustang Bio, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in MBIO / Mustang Bio, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2021-12-14 MBIO Achenbach Brian 4,374 1.8300 135 59.4750 8,004 358 89.19 3,947 49.32
2021-10-12 MBIO Achenbach Brian 4,450 2.2800 137 74.1000 10,146
2021-04-09 MBIO Achenbach Brian 2,423 3.3600 75 109.2000 8,141
2020-12-08 MBIO Achenbach Brian 5,185 3.0300 160 98.4750 15,711
2020-10-21 MBIO Achenbach Brian 3,056 2.9700 94 96.5250 9,076
2020-05-22 MBIO Achenbach Brian 880 3.0400 27 98.8000 2,675
2020-03-31 MBIO Achenbach Brian 3,033 2.6400 93 85.8000 8,007
2019-12-06 MBIO Achenbach Brian 6,144 3.6900 189 119.9250 22,671

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MBIO / Mustang Bio, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Brian Achenbach as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2021-12-16 2021-12-14 4 MBIO MUSTANG BIO, INC.
COMMON STOCK
S - Sale -4,374 144,729 -2.93 1.83 -8,004 264,854
2021-12-16 2021-12-08 4 MBIO MUSTANG BIO, INC.
COMMON STOCK
A - Award 22,500 149,103 17.77
2021-10-21 2021-10-12 4 MBIO MUSTANG BIO, INC.
COMMON STOCK
S - Sale -4,450 126,603 -3.40 2.28 -10,146 288,655
2021-04-16 2021-04-09 4 MBIO MUSTANG BIO, INC.
COMMON STOCK
S - Sale -2,423 131,053 -1.82 3.36 -8,141 440,338
2021-04-16 2020-12-08 4 MBIO MUSTANG BIO, INC.
COMMON STOCK
S - Sale -5,185 133,476 -3.74 3.03 -15,711 404,432
2021-04-16 2020-10-21 4 MBIO MUSTANG BIO, INC.
COMMON STOCK
S - Sale -3,056 138,661 -2.16 2.97 -9,076 411,823
2021-04-16 2020-05-22 4 MBIO MUSTANG BIO, INC.
COMMON STOCK
S - Sale -880 141,717 -0.62 3.04 -2,675 430,820
2021-04-16 2020-03-31 4 MBIO MUSTANG BIO, INC.
COMMON STOCK
S - Sale -3,033 142,597 -2.08 2.64 -8,007 376,456
2021-04-16 2019-12-06 4 MBIO MUSTANG BIO, INC.
COMMON STOCK
S - Sale -6,144 145,630 -4.05 3.69 -22,671 537,375
2021-03-15 2020-12-15 4 MBIO MUSTANG BIO, INC.
Common Stock
A - Award 22,500 151,774 17.40
2020-04-29 2020-03-26 4 MBIO MUSTANG BIO, INC.
Common Stock
A - Award 36,250 129,274 38.97
2020-04-29 2020-03-05 4 MBIO MUSTANG BIO, INC.
Common Stock
A - Award 524 93,024 0.57 2.48 1,300 230,700
2020-01-17 2019-04-16 4 MBIO MUSTANG BIO, INC.
Common Stock
A - Award 35,000 92,500 60.87
2018-12-03 2018-11-20 4 MBIO MUSTANG BIO, INC.
COMMON STOCK
P - Purchase 500 57,500 0.88 3.87 1,937 222,766
2018-12-03 2018-11-19 4 MBIO MUSTANG BIO, INC.
COMMON STOCK
P - Purchase 1,000 57,000 1.79 4.25 4,250 242,250
2018-12-03 2018-11-16 4 MBIO MUSTANG BIO, INC.
COMMON STOCK
P - Purchase 1,000 56,000 1.82 4.31 4,310 241,360
2018-12-03 2018-02-02 4 MBIO MUSTANG BIO, INC.
COMMON STOCK
A - Award 55,000 55,000
2018-11-27 3 MBIO MUSTANG BIO, INC.
Common Stock
0
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)